SCHEMBL1099356

SCHEMBL1099356

CCS(=O)(=O)N(CCOC(C)(C)C)c1sc2ccccc2c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.40
HSD11B1 P28845 1/20 0.34
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALK Q9UM73 1/20 0.31
LMNA P02545 3/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 4/20 0.30
USP2 O75604 1/20 0.30
HTT P42858 1/20 0.30
HSD17B10 Q99714 1/20 0.30
NPC1 O15118 1/20 0.30
GLA P06280 1/20 0.30
ALOX15 P16050 1/20 0.30
ALOX12 P18054 1/20 0.30
RAB9A P51151 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CMA1 P23946 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099500 0.89 TRPM8 (0.41) TRPM8HSD11B1ALDH1A1HPGDTSHR
SCHEMBL1098683 0.87 ALDH1A1 (0.32) TRPM8ALDH1A1HPGDTSHRKDM4E
SCHEMBL1100720 0.86 ALDH1A1 (0.44) TRPM8HSD11B1ALDH1A1HPGDTSHR
SCHEMBL1099844 0.86 TRPM8 (0.49) TRPM8HSD11B1KDM4E
SCHEMBL1098116 0.84 ALDH1A1 (0.36) TRPM8ALDH1A1HPGDTSHRKDM4E
SCHEMBL1099838 0.83 SLC6A9 (0.33) TRPM8ALDH1A1HPGDTSHRKDM4E
SCHEMBL1099130 0.81 TRPM8 (0.43) TRPM8HSD11B1ALDH1A1HPGDTSHR
SCHEMBL1099581 0.80 TRPM8 (0.62) TRPM8
SCHEMBL1100231 0.79 TRPM8 (0.39) TRPM8HSD11B1ALDH1A1HPGDTSHR
SCHEMBL1099978 0.77 TRPM8 (0.37) TRPM8HSD11B1ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885HSD11B1 4304/4885ALDH1A1 3091/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885HSD11B1 4304/4885ALDH1A1 3091/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885HSD11B1 4304/4885ALDH1A1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.